Peter BrownPrincipal Investigator, Epigenetic Chemical Probes SGC
Richard ChesworthExecutive Director, Molecular Discovery Epizyme
Keith DionneCEO Constellation Pharmaceuticals
Jonathan NorthrupCEO Salarius Pharmaceuticals
The 5th Annual EpiCongress, Boston is a premier networking, interactive and solution-led conference that addresses how understanding the mechanisms behind genome regulation and chromatin function can help provide new therapies.
This is a meeting where you will discover industry-defining information, and expand your network to achieve effective application of epigenetic science and ensure the success of your current and future drug candidates.
Organizations that attended last year:
Why Should You Attend?
Understanding the epigenetic mechanisms involved in a cells transformation will have a significant impact on disease prevention, diagnosis and therapy.
EpiCongress Boston will ensure you develop a cutting edge understanding for making clinically relevant predictions and tap into the potential of epigenetics to generate new epigenetic therapies: